Kajian klinikal Migrain di Texas
13 kajian untuk Migrain sedang mencari peserta di lokasi di Texas.
Bandar di Texas
Teks kajian rasmi (Bahasa Inggeris)
Study of EVO756 in Adults With Migraine
- FutureSearch Trials of Neurology, Austin
- FutureSearch Trials of Dallas, Dallas
- SFF Medical Research Group LLC, Houston
- dan 1 lagi
Mengambil pesertaFasa 2
Umur 18 hingga 64 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07616128Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
- Alina Clinical Trials, LLC., Dallas
- North Texas Center for Clinical Research, Frisco
- DM Clinical Research - Cy Fair, Houston
- dan 6 lagi
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05156398Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
- Dell Children's Medical Center, Austin
- Child Neurology Consultants of Austin - Central Austin, Austin
- Houston Clinical Trials, LLC, Bellaire
- dan 4 lagi
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04743141Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- Dell Children's Medical Center, Austin
- Houston Clinical Trials, LLC, Bellaire
- FutureSearch Trials of Dallas, LLC, Dallas
- dan 5 lagi
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT04649242A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
- UT Health Austin at Dell Childrens Neurology Clinic /ID# 270577, Austin
- Earle Research /ID# 270424, Houston
- Clinpoint Trials /ID# 270261, Waxahachie
Mengambil pesertaFasa 3
Umur 12 hingga 17 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT06810505Responding With Evidence and Access for Childhood Headaches
- Dell Children's Hospital-UT Health, Austin
Mengambil peserta
Umur 10 hingga 17 · Semua jantina · Dikemas kini 21 Sep 2026 · NCT05889624Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- DHR Health Headache Center, McAllen
Mengambil pesertaFasa 4
Umur 18 hingga 70 · Semua jantina · Dikemas kini 16 Sep 2026 · NCT06972056Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
- UT Health Austin at Dell Children's Neurology Clinic /ID# 244266, Austin
- Austin Regional Clinic - ARC Four Points /ID# 276301, Austin
- Velocity Clinical Research, Austin /ID# 230557, Austin
- dan 13 lagi
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 14 Sep 2026 · NCT05125302A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- FutureSearch Trials of Neurology, Austin
- Tekton Research, Austin
- APD Clinical Research, Cypress
- dan 7 lagi
Mengambil pesertaFasa 3
Umur 18 hingga 75 · Semua jantina · Dikemas kini 20 Ogo 2026 · NCT07645924A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Road Runner Research Ltd, San Antonio
Mengambil pesertaFasa 3
Umur 6 hingga 17 · Semua jantina · Dikemas kini 12 Jun 2026 · NCT05164172A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine
- FutureSearch Trials, Austin
Mengambil pesertaFasa 2
Umur 18 hingga 70 · Semua jantina · Dikemas kini 19 Mei 2026 · NCT06602479Does Nerve Block + Oral Dexamethasone Reduce Recurrence of Headache Within 72 Hrs?
- University Medical Center of El Paso, El Paso
Mengambil pesertaFasa awal 1
Umur 18 hingga 85 · Semua jantina · Dikemas kini 6 Mei 2026 · NCT06016465Stimulation of External Carotid Artery Circulation
- University of Texas Medical Branch, Galveston
Mengambil peserta
Umur 18 hingga 100 · Semua jantina · Dikemas kini 20 Feb 2026 · NCT07402954Daripada ClinicalTrials.gov, data diperoleh pada 4 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.